Lancaster General Health Plans to Expand Cancer Center

Lancaster General Health is planning a $38 million expansion of their cancer center.

Some cancer drugs are great at keeping patients in remission, but they don’t know about them– or don’t want to take them

There are four anti-cancer drugs that are effective, but rarely taken because of their harsh side effects.

Woman Sues Wilkes-Barre General Hospital for Testing Wrong Kidney

Renee Deyo is suing Wilkes Barre General Hospital for allowing a treatable form of cancer to spread because they conducted tests on the wrong kidney multiple times.

Less Agreesive Methods of Bone Marrow Transplants May Lead to More Uses

New methods of bone marrow transplants are less invasive and offer more hope for individuals suffering from a variety of diseases.

New study contends that increased breast cancer screening does not result in decreased death rates

The study is sure to add fuel to the fire over breast cancer screening guidelines.

New blood test of tumors to find out their DNA may create more effective treatment plans

The findings suggest that by testing blood for this fingerprint, doctors will be able to learn whether a patient treated for cancer is free of disease or needs additional or more aggressive care, reports the Wall Street Journal.

New study suggests that aspirin use may reduce risk of death from breast cancer

In the study, reports Reuters, women who took aspirin two to five days a week had a 60 percent reduced risk of their cancer spreading and a 71 percent lower risk of breast cancer death. Six to seven aspirins a week lowered the risk of spread by 43 percent and the risk of breast cancer death by 64 percent.

Cytokinetics ends cancer deal with GlaxoSmithKline

Philadelphia Inq reports:

NEW YORK – Cytokinetics Inc. said Wednesday it ended a deal with GlaxoSmithKline PLC that had focused on developing a potential cancer treatment, sending shares sharply lower in after-hours trading.
Cytokinetics said, effective Feb. 28, all rights for the potential cancer treatment GSK-923295 will revert back to the biotechnology company. GlaxoSmithKline will still be [...]